TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.1920
+0.0023 (1.21%)
Oct 27, 2026, 4:00 PM EDT - Market closed
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $13.01 million as of October 27, 2026. It is the 39,862nd most valuable company in the world and the 5,437th biggest in the United States. Its market cap has decreased by 90.07% in one year.
Market Cap
13.01M
Enterprise Value
3.75M
1-Year Change
-90.07%
Global Rank
Country Rank
#5,437 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $13.01M, a decrease of -96.38%. That is a compound annual growth rate of -46.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 13.01M | -77.07% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 14.57M |
| Dyadic International | 14.54M |
| Fractyl Health | 14.33M |
| BioCardia | 13.94M |
| Allarity Therapeutics | 13.77M |
| Pasithea Therapeutics | 13.53M |
| Daré Bioscience | 12.70M |
| SeaStar Medical Holding | 12.68M |